IL1B and metabolic dysfunction-associated steatotic liver disease: After bicyclol-treated, the levels of TNF-α and IL-1β were decreased and the pathological and ultrastructural changes of liver tissue are also weakened, it is demonstrated that bicyclol markedly inhibiting the inflammation in T2DM–NAFLD rat.